TK

Tooba Kausar Mohammed Kaleem

Active Director Director DIN 10362311
DIN 10362311 First appointment Oct 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Tooba Kausar Mohammed Kaleem

Data last updated:

Tooba Kausar Mohammed Kaleem is a Director at Gorwal Pharmaceuticals India Private Limited (since 2023). The company operates in Pharma.

DIN 10362311
Primary Designation Director
Industry Pharma
First Appointment 18 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Oct 20232023Active

Board colleagues of Tooba Kausar Mohammed Kaleem

NameDINCompanyDesignation
Jafar Iqbal10362312Gorwal Pharmaceuticals India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Gorwal Pharmaceuticals India Private Limited
Premium access

Shareholding and investment profile for Tooba Kausar Mohammed Kaleem

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tooba Kausar Mohammed Kaleem

Tooba Kausar Mohammed Kaleem currently holds 1 directorship: Gorwal Pharmaceuticals India Private Limited (Director, since 18 Oct 2023).

Tooba Kausar Mohammed Kaleem was first appointed on 18 Oct 2023 as Director at Gorwal Pharmaceuticals India Private Limited.

The current boards of Tooba Kausar Mohammed Kaleem's companies include Jafar Iqbal (Gorwal Pharmaceuticals India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available